These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30787671)

  • 1. Low-dose zoledronate for the treatment of bone metastasis secondary to prostate cancer.
    Akoury E; Ahangar P; Nour A; Lapointe J; Guérard KP; Haglund L; Rosenzweig DH; Weber MH
    Cancer Cell Int; 2019; 19():28. PubMed ID: 30787671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Tumor Effects of Low Dose Zoledronate on Lung Cancer-Induced Spine Metastasis.
    Akoury E; Ramirez Garcia Luna AS; Ahangar P; Gao X; Zolotarov P; Weber MH; Rosenzweig DH
    J Clin Med; 2019 Aug; 8(8):. PubMed ID: 31416169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone-Targeted Calcium Phosphate-Polymer Hybrid Nanoparticle Co-Deliver Zoledronate and Docetaxel to Treat Bone Metastasis of Prostate Cancer.
    Yang Q; Liu DZ; Liu M; Ji QF; Mei QB; Cheng Y; Zhou SY
    J Pharm Sci; 2021 Feb; 110(2):876-887. PubMed ID: 33166581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoporous 3D-Printed Scaffolds for Local Doxorubicin Delivery in Bone Metastases Secondary to Prostate Cancer.
    Ahangar P; Akoury E; Ramirez Garcia Luna AS; Nour A; Weber MH; Rosenzweig DH
    Materials (Basel); 2018 Aug; 11(9):. PubMed ID: 30134523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD73 regulates zoledronate-induced lymphocyte infiltration in triple-negative breast cancer tumors and lung metastases.
    Petruk N; Siddiqui A; Tadayon S; Määttä J; Mattila PK; Jukkola A; Sandholm J; Selander KS
    Front Immunol; 2023; 14():1179022. PubMed ID: 37533856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folate-targeted pH-responsive calcium zoledronate nanoscale metal-organic frameworks: Turning a bone antiresorptive agent into an anticancer therapeutic.
    Au KM; Satterlee A; Min Y; Tian X; Kim YS; Caster JM; Zhang L; Zhang T; Huang L; Wang AZ
    Biomaterials; 2016 Mar; 82():178-93. PubMed ID: 26763733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-tumor delivery of zoledronate mitigates metastasis-induced osteolysis superior to systemic administration.
    Nooh A; Zhang YL; Sato D; Rosenzweig DH; Tabariès S; Siegel P; Barralet JE; Weber MH
    J Bone Oncol; 2017 Mar; 6():8-15. PubMed ID: 28138422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic inhibitory activity of zoledronate and paclitaxel on bone metastasis in nude mice.
    Lu S; Zhang J; Zhou Z; Liao ML; He WZ; Zhou XY; Li ZM; Xiang JQ; Wang JJ; Chen HQ
    Oncol Rep; 2008 Sep; 20(3):581-7. PubMed ID: 18695909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective intra-individual comparison of [
    Lawal IO; Mokoala KMG; Mahapane J; Kleyhans J; Meckel M; Vorster M; Ebenhan T; Rösch F; Sathekge MM
    Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):134-142. PubMed ID: 32424485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zoledronic acid inhibits visceral metastases in the 4T1/luc mouse breast cancer model.
    Hiraga T; Williams PJ; Ueda A; Tamura D; Yoneda T
    Clin Cancer Res; 2004 Jul; 10(13):4559-67. PubMed ID: 15240548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-targeting Salmonella typhimurium A1-R inhibits human prostate cancer experimental bone metastasis in mouse models.
    Toneri M; Miwa S; Zhang Y; Hu C; Yano S; Matsumoto Y; Bouvet M; Nakanishi H; Hoffman RM; Zhao M
    Oncotarget; 2015 Oct; 6(31):31335-43. PubMed ID: 26431498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combined use of Camellia sinensis and metronomic zoledronate in 4T1 mouse carcinoma against tumor growth and metastasis.
    Luo KW; Yue GG; Ko CH; Gao S; Lee JK; Li G; Fung KP; Leung PC; Lau CB
    Oncol Rep; 2015 Jul; 34(1):477-87. PubMed ID: 25998578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases.
    Ibrahim A; Scher N; Williams G; Sridhara R; Li N; Chen G; Leighton J; Booth B; Gobburu JV; Rahman A; Hsieh Y; Wood R; Vause D; Pazdur R
    Clin Cancer Res; 2003 Jul; 9(7):2394-9. PubMed ID: 12855610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodistribution and post-therapy dosimetric analysis of [
    Khawar A; Eppard E; Roesch F; Ahmadzadehfar H; Kürpig S; Meisenheimer M; Gaertner FC; Essler M; Bundschuh RA
    EJNMMI Res; 2019 Nov; 9(1):102. PubMed ID: 31781962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
    Li YY; Chang JW; Chou WC; Liaw CC; Wang HM; Huang JS; Wang CH; Yeh KY
    Lung Cancer; 2008 Feb; 59(2):180-91. PubMed ID: 17900752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonates modulate vital functions of human osteoblasts and affect their interactions with breast cancer cells.
    Kaiser T; Teufel I; Geiger K; Vater Y; Aicher WK; Klein G; Fehm T
    Breast Cancer Res Treat; 2013 Jul; 140(1):35-48. PubMed ID: 23807419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of zoledronic acid treatment patterns and clinical outcomes in patients with bone metastases from genitourinary cancers.
    Henk HJ; Kaura S
    J Med Econ; 2012; 15(1):185-94. PubMed ID: 22168786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled delivery of zoledronate improved bone formation locally in vivo.
    Gou W; Wang X; Peng J; Lu Q; Wang Y; Wang A; Guo Q; Gao X; Xu W; Lu S
    PLoS One; 2014; 9(3):e91317. PubMed ID: 24618585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zoledronic acid - a multiplicity of anti-cancer action.
    Yuasa T; Kimura S; Ashihara E; Habuchi T; Maekawa T
    Curr Med Chem; 2007; 14(20):2126-35. PubMed ID: 17691952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zoledronate effects on systemic and jaw osteopenias in ovariectomized periostin-deficient mice.
    Bonnet N; Lesclous P; Saffar JL; Ferrari S
    PLoS One; 2013; 8(3):e58726. PubMed ID: 23505553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.